Drug profile

The FDA adverse-event record for Ciclosporin

10 FDA reports name Ciclosporin, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#2554 of 2,679
by report volume (all drugs)
10
adverse-event reports
0.0%
death-coded share
Unknown
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Ciclosporin ranks #2536 of 2679 by total reports (10). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#2536
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Signature read: 10 reports place Ciclosporin in the lower third of FDA AER volume (#2554 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
0
Deaths Reported
0.0%
Death-coded share of reports

Active Ingredients

Ciclosporin

Administration Routes

UnknownOral

Species Affected

Unknown 5
Cat 3
Dog 2

Most Affected Breeds

Unknown 5
Persian 1
Crossbred Canine/dog 1
Maine Coon 1
Domestic Shorthair 1
Retriever - Golden 1

Most Reported Reactions

Vomiting 4
Decreased appetite 2
Product defect, product difficult to use/handle (see also 'Drug device difficult to use/handle') 2
UNPALATABLE 2
Cardiac disorder NOS 2
Drooling 1
Pancreatitis NOS 1
Enteritis 1
Urinary tract infection 1
Azotaemia 1
Ureteric disorder 1
Dilated renal pelvis 1

Outcome Breakdown

Ongoing
3 (60.0%)
Recovered/Normal
2 (40.0%)

Ciclosporin: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Ciclosporin (#2554 of 2,679 by report volume); death-coded 0.0%. PlainBreed drug row · report volume stamp 10 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →